Transaction in Own Shares
Rhea-AI Summary
Shell (SHEL) purchased and will cancel 776,817 ordinary shares on 06 March 2026 as part of its ongoing buy-back programme announced 05 February 2026.
The purchases were executed across LSE, Chi-X, BATS, XAMS, CBOE DXE and TQEX, with Morgan Stanley making independent trading decisions through 01 May 2026.
Positive
- Shares repurchased: 776,817 on 06 March 2026
- Purchases designated for cancellation under the buy-back programme
- Buy-back executed across six trading venues (LSE, Chi-X, BATS, XAMS, CBOE DXE, TQEX)
- Morgan Stanley to trade independently for the programme until 01 May 2026
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
SHEL gained 0.29% while momentum names like PBR and EQNR showed stronger upside moves of about 5%. With limited peers in the scanner and mixed moves across CVX, XOM, TTE, and BP, today’s action appears more company-specific than a broad sector rotation.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 05 | Share buy-back | Positive | +0.3% | Purchase and cancellation of 1,109,500 shares under ongoing buy-back. |
| Mar 05 | PDMR shareholding | Neutral | +0.3% | Vesting of 2023 Long Term Incentive Plan awards to senior management. |
| Mar 04 | Share buy-back | Positive | +0.5% | Repurchase and cancellation of 1,949,746 shares across multiple venues. |
| Mar 04 | PDMR share award | Neutral | +0.5% | Conditional award of 11,269 shares to a senior executive under share plan. |
| Mar 03 | Share buy-back | Positive | -2.2% | Purchase and cancellation of 2,060,266 shares under existing programme. |
Recent buy-back and management share-deal news has generally coincided with small, mostly positive price reactions, with one notable negative divergence.
Over the past few days, Shell has repeatedly reported buy-backs and management share-related disclosures. On 03–05 Mar 2026, multiple "Transaction in Own Shares" releases detailed cancellations of between 1.1M and 2.06M shares, while separate Director/PDMR announcements covered incentive awards and vestings. Price reactions around these events have mostly been modestly positive, indicating the market has treated the ongoing capital return and equity-award updates as routine.
Market Pulse Summary
This announcement details another day of Shell’s ongoing share buy-back programme, with purchases across LSE, Chi-X, BATS, XAMS, CBOE DXE, and TQEX under EU MAR and UK MAR rules. Combined with recent disclosures of additional buy-backs and management share awards, it underscores a consistent capital-return framework. Investors may watch aggregate repurchase volumes, execution across venues, and how frequently these transactions are reported through the current window ending 01 May 2026.
Key Terms
buy-back programme financial
off-market buyback contract financial
eu mar regulatory
uk mar regulatory
market abuse (amendment) (eu exit) regulations (si 2019/310) regulatory
AI-generated analysis. Not financial advice.
Transaction in Own Shares
06 March 2026
• • • • • • • • • • • • • • • •
Shell plc (the ‘Company’) announces that on 06 March 2026 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
| Date of Purchase | Number of Shares purchased | Highest price paid | Lowest price paid | Volume weighted average price paid per share | Venue | Currency |
| 06/03/2026 | 269,086 | 31.5350 | 30.9650 | 31.2806 | LSE | GBP |
| 06/03/2026 | 89,596 | 31.5200 | 31.0450 | 31.2974 | Chi-X (CXE) | GBP |
| 06/03/2026 | 43,953 | 31.5200 | 30.9900 | 31.2576 | BATS (BXE) | GBP |
| 06/03/2026 | 211,929 | 36.4050 | 35.6900 | 36.1042 | XAMS | EUR |
| 06/03/2026 | 133,526 | 36.3450 | 35.7000 | 36.0929 | CBOE DXE | EUR |
| 06/03/2026 | 28,727 | 36.4050 | 35.7450 | 36.1283 | TQEX | EUR |
These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 05 February 2026.
In respect of this programme, Morgan Stanley & Co. International Plc will make trading decisions in relation to the securities independently of the Company for a period from 05 February 2026 up to and including 01 May 2026.
The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.
In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Morgan Stanley & Co. International Plc on behalf of the Company as a part of the buy-back programme is detailed below.
Enquiries
Media: International +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html
Attachment